ADC Therapeutics ADCT
NYSE ADCT
$1.52 +0.08 (+5.90%)
As of: Oct 20, 2026 · 3:59 PM EDT

ADC Therapeutics (ADCT) Total Non-Current Liabilities (2019 - 2026)

Updated

ADC Therapeutics (ADCT) posted Total Non-Current Liabilities of $208.04 million for Q2 2026, up 11.0% from $187.5 million a year earlier and up 2.4% from the prior quarter.

Analysis

ADC Therapeutics (ADCT) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, ADC Therapeutics' Total Non-Current Liabilities came in at $186.46 million, down 8.8% from FY2024.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of 6.2% (FY2020 to FY2025).
  • In prior years, ADC Therapeutics' Total Non-Current Liabilities was $204.53 million in FY2024 (+2.5%), $199.46 million in FY2023 (-41.6%), $341.48 million in FY2022 (-9.6%) and $377.95 million in FY2021 (+174.4%).
  • The Q2 2026 figure stands as the highest quarterly Total Non-Current Liabilities since Q3 2023.
  • On a year-over-year basis, Total Non-Current Liabilities increased in four of the last eight quarters, with an average decline of 6.2%.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q1 2022, with growth of 184.8%; the weakest was Q2 2024, with a decline of 57.0%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $203.19 million (Q1 2026), $186.46 million (Q4 2025) and $187.77 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 105.50 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 106.45 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 33.91 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 35.10 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 97.04 Bn
10 ADC Therapeutics 235.62 Mn -710.57 Mn 16.90 Mn 197.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 197.72 Mn
Mar 31, 2026 179.66 Mn
Dec 31, 2025 183.65 Mn
Sep 30, 2025 178.38 Mn
Jun 30, 2025 180.33 Mn
Mar 31, 2025 179.52 Mn
Dec 31, 2024 202.10 Mn
Sep 30, 2024 190.75 Mn
Jun 30, 2024 180.61 Mn
Mar 31, 2024 185.88 Mn
Dec 31, 2023 190.58 Mn
Sep 30, 2023 442.88 Mn
Jun 30, 2023 435.31 Mn
Mar 31, 2023 348.90 Mn
Dec 31, 2022 341.48 Mn
Sep 30, 2022 339.40 Mn
Jun 30, 2022 331.43 Mn
Mar 31, 2022 348.45 Mn
Dec 31, 2021 377.95 Mn
Sep 30, 2021 391.37 Mn
API Access

ADC Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ADCT&period=max&api_key=YOUR_API_KEY